Publications

Pharmacogenomics and personalized medicine: mapping of future value creation
Sean X. Hu, Thomas Foster and Ann Kieffaber.
October, 2005
The Unlikely European Biotech Poker Game
EBR
Catherine Pichereau looks at the difficulties European biotech companies encounter raising public funds.
Summer, 2005
Vioxx: Lifting the Veil on the Dark Side of the Pharmaceutical Industry
EBR
Catherine Pichereau examines the consequences of the Vioxx scandal.
Spring, 2005
Entry in Europe – Companies from Overseas Face Critical Issues
Biotechnology in Europe Today
Mark Larkin explores the issues faced by companies considering becoming players in the European market.
Autumn, 2004
Risky Business
Scrip Magazine
Alain Gilbert and Mark Larkin discuss how European Biotech companies can be sustainable in a risk-averse environment.
September, 2004
EU biotech: United we Stand, Divided we Fall
Scrip Magazine
Claude Allary and Catherine Pichereau look at the results of a survey examining why there are so few biotech consolidations in Europe, and suggest ways to increase their number.
July/August, 2004
Local Brand Strategy is the Weakest Link
Scrip Magazine
Lionel Delaporte, Loic Plantevin and Kate Parker explore why local brand strategic planning is becoming increasingly critical
December, 2003
1 3 4 5